Clinical Trial Results:
Double-blind, randomised, placebo-controlled trial of levetiracetam for central neuropathic pain in patients with multiple sclerosis
Summary
|
|
EudraCT number |
2006-000397-71 |
Trial protocol |
DK |
Global completion date |
12 Jan 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
26 May 2021
|
First version publication date |
26 May 2021
|
Other versions |
|
Summary report(s) |
Levetiracetam in central pain in multiple sclerosis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.